Moderna MRNA Total Cost of Revenue
Total Cost of Revenue at other companies
Other financials
Where this comes from
Reported directly by Moderna in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: Moderna’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Moderna's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Moderna's total cost of revenue?
- Moderna (MRNA) reported total cost of revenue of $955M in Q1 2026.
- How has Moderna's total cost of revenue changed year-over-year?
- Moderna's total cost of revenue increased by 961.1% year-over-year, from $90M to $955M.
- What is the long-term trend for Moderna's total cost of revenue?
- Over 4 years (2021 to 2025), Moderna's total cost of revenue has grown at a -24.1% compound annual growth rate (CAGR), from $2.62B to $868M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.